Phaseline

Targets › ITGA6

ITGA6 (Integrin alpha-6): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Oncology; next expected readout Dec 2034.

Integrin alpha-6/beta-1 (ITGA6:ITGB1) is a receptor for laminin on platelets (By similarity). Integrin alpha-6/beta-1 (ITGA6:ITGB1) is present in oocytes and is involved in sperm-egg fusion (By similarity). (UniProt, P23229)

Open in Phaseline: the race on ITGA6, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Institute of Automation, Chinese Academy of SciencesRD-Cy7 fluorophore
ITGA6-targeting NIR-II fluorescence imaging probe
ITGA6Phase 1Hepatocellular CarcinomaDec 2034

Conditions

Hepatocellular Carcinoma (1)

Modalities

small molecule (1)

Companies

Institute of Automation, Chinese Academy of Sciences (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.